Home / Liraglutide / United States
US ATC A10BJ02 · updated 2 Nov 2026
Liraglutide shortage in United States
Is there a Liraglutide shortage in United States?
Yes. As of 2 Nov 2026, 11 Liraglutide products are reported short in United States, the first since 18 Jul 2023. No return date has been given. Main reason: not stated.
Also short in Canada, Spain, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) | Hikma Pharmaceuticals USA, Inc. | 18 Jul 2023 | not given | Not stated |
| US | Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) | Hikma Pharmaceuticals USA, Inc. | 18 Jul 2023 | not given | Not stated |
| US | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) | Novo Nordisk, Inc. | 18 Jul 2023 | not given | Not stated |
| US | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) | Novo Nordisk, Inc. | 18 Jul 2023 | not given | Not stated |
| US | Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84) | Meitheal Pharmaceuticals, Inc. | 18 Jul 2023 | not given | Not stated |
| US | Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85) | Meitheal Pharmaceuticals, Inc. | 18 Jul 2023 | not given | Not stated |
| US | Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) limited discontinuation | Novo Nordisk, Inc. | 18 Jul 2023 | not given | Manufacturing problem Discontinuation of the manufacture of the drug |
| US | Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) limited | Novo Nordisk, Inc. | 18 Jul 2023 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) limited | Novo Nordisk, Inc. | 18 Jul 2023 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46) discontinuation | Teva Pharmaceuticals USA, Inc. | 14 May 2026 | not given | Not stated |
| US | Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) discontinuation | Novo Nordisk, Inc. | 25 Aug 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).